Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 生理學科所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/22191
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor蘇慧敏
dc.contributor.authorShang-Jung Chengen
dc.contributor.author鄭上容zh_TW
dc.date.accessioned2021-06-08T04:13:37Z-
dc.date.copyright2010-09-09
dc.date.issued2010
dc.date.submitted2010-08-16
dc.identifier.citation(1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 350:1047-1059.
Baud V, Karin M (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8:33-40.
Biswas DK, Iglehart JD (2006) Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer. J Cell Physiol 209:645-652.
Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB, Iglehart JD (2004) NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci U S A 101:10137- 10142.
Brash AR (2001) Arachidonic acid as a bioactive molecule. J Clin Invest 107:1339-1345.
Brunner N, Boulay V, Fojo A, Freter CE, Lippman ME, Clarke R (1993) Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Cancer Res 53:283-290.
Calder PC (2008) Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 52:885-897.
Cao Y, Karin M (2003) NF-kappaB in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 8:215-223.
Cho SG, Li D, Stafford LJ, Luo J, Rodriguez-Villanueva M, Wang Y, Liu M (2009) KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation. J Cell Biochem 107:1139-1149.
Cicenas J, Urban P, Vuaroqueaux V, Labuhn M, Kung W, Wight E, Mayhew M, Eppenberger U, Eppenberger-Castori S (2005) Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2. Breast Cancer Res 7:R394-401.
Cooper S (2003) Reappraisal of serum starvation, the restriction point, G0, and G1 phase arrest points. FASEB J 17:333-340.
Cooper S, Gonzalez-Hernandez M (2009) Experimental reconsideration of the utility of serum starvation as a method for synchronizing mammalian cells. Cell Biol Int 33:71-77.
Covey TM, Edes K, Fitzpatrick FA (2007) Akt activation by arachidonic acid metabolism occurs via oxidation and inactivation of PTEN tumor suppressor. Oncogene 26:5784-5792.
Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landesman- Bollag E, Seldin DC, Sonenshein GE (2005) RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Mol Cell Biol 25:10136-10147.
Ennis HL, Lubin M (1964) Cycloheximide: Aspects of Inhibition of Protein Synthesis in Mammalian Cells. Science 146:1474-1476.
Frasor J, Weaver A, Pradhan M, Dai Y, Miller LD, Lin CY, Stanculescu A (2009) Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. Cancer Res 69:8918-8925.
Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54:1812-1817.
Gionet N, Jansson D, Mader S, Pratt MA (2009) NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor- negative and -positive hormone-independent breast cancer cells. J Cell Biochem 107:448-459.
Godley PA (1995) Essential fatty acid consumption and risk of breast cancer. Breast Cancer Res Treat 35:91-95.
Hacker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006:re13.
Hilakivi-Clarke L, Clarke R, Lippman M (1999) The influence of maternal diet on breast cancer risk among female offspring. Nutrition 15:392-401.
Hwang TS, Han HS, Hong YC, Lee HJ, Paik NS (2003) Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients. Pathol Int 53:74-80.
Hyde CA, Missailidis S (2009) Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. Int Immunopharmacol 9:701-715.
Joyce D, Albanese C, Steer J, Fu M, Bouzahzah B, Pestell RG (2001) NF- kappaB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev 12:73-90.
Kang JX, Weylandt KH (2008) Modulation of inflammatory cytokines by omega- 3 fatty acids. Subcell Biochem 49:133-143.
Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441:431-436.
Key TJ, Verkasalo PK (1999) Endogenous hormones and the aetiology of breast cancer. Breast Cancer Res 1:18-21.
Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet Oncol 2:133-140.
Kim NH, Jeon S, Lee HJ, Lee AY (2007) Impaired PI3K/Akt activation-mediated NF-kappaB inactivation under elevated TNF-alpha is more vulnerable to apoptosis in vitiliginous keratinocytes. J Invest Dermatol 127:2612-2617.
Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguere V (2005) From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci U S A 102:11651-11656.
Liu M, Ju X, Willmarth NE, Casimiro MC, Ojeifo J, Sakamaki T, Katiyar S, Jiao X, Popov VM, Yu Z, Wu K, Joyce D, Wang C, Pestell RG (2009) Nuclear

factor-kappaB enhances ErbB2-induced mammary tumorigenesis and
neoangiogenesis in vivo. Am J Pathol 174:1910-1920. Lo CY, Hsieh PH, Chen HF, Su HM (2009) A maternal high-fat diet during
pregnancy in rats results in a greater risk of carcinogen-induced mammary tumors in the female offspring than exposure to a high-fat diet in postnatal life. Int J Cancer 125:767-773.
Maskarinec G (2000) Breast cancer--interaction between ethnicity and environment. In Vivo 14:115-123.
Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M Genetic susceptibility to breast cancer. Mol Oncol.
Misra RS, Russell JQ, Koenig A, Hinshaw-Makepeace JA, Wen R, Wang D, Huo H, Littman DR, Ferch U, Ruland J, Thome M, Budd RC (2007) Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation. J Biol Chem 282:19365-19374.
O'Shea JM, Perkins ND (2008) Regulation of the RelA (p65) transactivation domain. Biochem Soc Trans 36:603-608.
Osawa Y, Nagaki M, Banno Y, Brenner DA, Nozawa Y, Moriwaki H, Nakashima S (2003) Expression of the NF-kappa B target gene X-ray-inducible immediate early response factor-1 short enhances TNF-alpha-induced hepatocyte apoptosis by inhibiting Akt activation. J Immunol 170:4053- 4060.
Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE (2001) Her- 2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 20:1287-1299.
Pidgeon GP, Lysaght J, Krishnamoorthy S, Reynolds JV, O'Byrne K, Nie D, Honn KV (2007) Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev 26:503-524.
Prasad S, Ravindran J, Aggarwal BB NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem 336:25-37.
Pratt MA, Bishop TE, White D, Yasvinski G, Menard M, Niu MY, Clarke R (2003) Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence. Mol Cell Biol 23:6887-6900.
Ramakers JD, Mensink RP, Schaart G, Plat J (2007) Arachidonic acid but not eicosapentaenoic acid (EPA) and oleic acid activates NF-kappaB and elevates ICAM-1 expression in Caco-2 cells. Lipids 42:687-698.
Roy PG, Thompson AM (2006) Cyclin D1 and breast cancer. Breast 15:718- 727.
Rubio MF, Werbajh S, Cafferata EG, Quaglino A, Colo GP, Nojek IM, Kordon EC, Nahmod VE, Costas MA (2006) TNF-alpha enhances estrogen- induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Oncogene 25:1367-1377.
Shin JS, Hong SW, Lee SL, Kim TH, Park IC, An SK, Lee WK, Lim JS, Kim KI, Yang Y, Lee SS, Jin DH, Lee MS (2008) Serum starvation induces G1

arrest through suppression of Skp2-CDK2 and CDK4 in SK-OV-3 cells.
Int J Oncol 32:435-439. Shoker BS, Jarvis C, Davies MP, Iqbal M, Sibson DR, Sloane JP (2001)
Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. Br J Cancer 84:1064-1069.
Singh S, Shi Q, Bailey ST, Palczewski MJ, Pardee AB, Iglehart JD, Biswas DK (2007) Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer. Mol Cancer Ther 6:1973- 1982.
Solakivi T, Kunnas T, Karkkainen S, Jaakkola O, Nikkari ST (2009) Arachidonic acid increases matrix metalloproteinase 9 secretion and expression in human monocytic MonoMac 6 cells. Lipids Health Dis 8:11.
Tapiero H, Ba GN, Couvreur P, Tew KD (2002) Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed Pharmacother 56:215-222.
Tsubura A, Uehara N, Kiyozuka Y, Shikata N (2005) Dietary factors modifying breast cancer risk and relation to time of intake. J Mammary Gland Biol Neoplasia 10:87-100.
Vinothini G, Balachandran C, Nagini S (2009) Evaluation of molecular markers in canine mammary tumors: correlation with histological grading. Oncol Res 18:193-201.
Wu Y, Zhou BP TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer 102:639-644.
Yoon H, Liu RH (2008) Effect of 2alpha-hydroxyursolic acid on NF-kappaB activation induced by TNF-alpha in human breast cancer MCF-7 cells. J Agric Food Chem 56:8412-8417.
Zhou Y, Eppenberger-Castori S, Eppenberger U, Benz CC (2005a) The NFkappaB pathway and endocrine-resistant breast cancer. Endocr Relat Cancer 12 Suppl 1:S37-46.
Zhou Y, Eppenberger-Castori S, Marx C, Yau C, Scott GK, Eppenberger U, Benz CC (2005b) Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers. Int J Biochem Cell Biol 37:1130-1144.
Zimmermann O, Zwaka TP, Marx N, Torzewski M, Bucher A, Guilliard P, Hannekum A, Hombach V, Torzewski J (2006) Serum starvation and growth factor receptor expression in vascular smooth muscle cells. J Vasc Res 43:157-165.
黃湘茹,民國96年,探討花生四烯酸對人類乳腺癌細胞進行細胞凋亡之研究。生理學研究所,臺 灣大學

呂怡芬,民國96年,探討DHA對人類乳癌細胞雌激素接受器α分布之影響。生理學研究所,臺灣 大學
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/22191-
dc.description.abstract花生四烯酸(Arachidonic acid ,AA ; C20:4 n-6)為多元不飽和脂肪酸,其多 種代謝產物在發炎反應中扮演調控角色。慢性發炎與癌化間關係於近年來多受關 注,在發炎反應中扮演整合中樞的轉錄因子NF-κB於乳癌中也發現過度活化。在 本實驗室先前研究中發現大鼠乳腺腫瘤之重量與AA含量成正比,顯現該脂肪酸 對於乳癌增生可能具調控作用。故本實驗以添加不同濃度AA的細胞模型模擬不 同重量腫瘤環境,觀察在TNF-α活化NF-κB傳訊過程中AA是否會透過影響Akt路 徑改變NF-κB相關蛋白表現量,並另以SD大鼠的乳腺腫瘤進行分析驗證。
本研究細胞實驗部份利用雌激素受體α陽性(ER+)人類乳癌細胞株MCF-7,培 養在含有0.1%胎牛血清的DMEM培養液中,以不同濃度(0、10、50、100 μM)的 AA處理,而後施以10 ng/mL TNF-α(視觀察項目更改刺激時間)。結果顯示p-Akt 活化程度會隨著AA濃度上升而增加,在10、50、100 μM時分別為控制組(0 μM) 的0.97、1.33、1.52倍。在免疫螢光染色方面,施以100 μM AA時也觀察到NF-κB 單體p65進入細胞核之現象。給予100 μM AA時,Akt磷酸化程度以90分鐘為分界 點先升後降,活化程度為控制組(0 分鐘)的4.83倍。至於細胞質內的NF-κB抑制 分子IκBα則會隨施加時間增加而逐漸分解,於20分鐘分解比例即佔79%,且該效 應在120分鐘內均維持在80%左右,直至180~240分鐘分解狀況方趨緩。在核質分 離樣本中觀察到,構成NF-κB常見二聚體中的p65蛋白質,隨AA濃度增加進入細 胞核比例亦漸增,在10、50、100 μM下分別是控制組的1.23、1.45以及1.59倍。 若添加Akt抑制劑阻斷傳訊時,可觀察到IκBα蛋白表現量比僅添加AA 100 μM 高,自控制組的46.3%回復至57.7%,顯現兩者傳訊途徑具上下游關係。然而, NF-κB下游的蛋白cyclin-D1隨AA濃度上升(0、10、50、100 μM)表現量卻漸減, 分別為控制組(0 μM)的45.4%、28.6%至28.1%。
動物組織實驗方面則印證了細胞實驗的結果,將乳腺腫瘤依照重量分類,進 行蛋白質萃取、電泳檢定,觀察目標蛋白p-Akt、p65、IκBα和cyclin-D1之表現與 腫瘤重量間是否具相關性。結果顯示,乳腺重量與Akt磷酸化、IκBα分解量之間 具正比關係,R值分別為0.6993、0.5319,且前者具統計顯著性(p<0.001)。而NF-κB 單體p65和NF-κB下游蛋白cyclin-D1表現,前者隨重量增加而上升(R值為0.6282, p=0.0287),後者則隨重量增加表現漸減(R值為0.7652,p<0.0001)。結果均與細胞 實驗觀察達一致。



本實驗發現,以TNF-α促使乳腺癌細胞株NF-κB活化時,添加AA會以活化 Akt的方式增強該傳訊途徑下游蛋白表現,且於動物模式中亦得到相同結論。故 推論AA在乳腺腫瘤中是以協助性角色影響NF-κB傳訊途徑,促進腫瘤增生、惡 化。應用於臨床上或許可透過降低目標器官中AA含量使乳癌惡化程度降低,進 而達到治療與延緩轉移之目的。
zh_TW
dc.description.abstractOur Lab previous found that arachidonic acid (AA, 20:4n-6) levels are 10 times higher in mammary tumor tissue than in the normal mammary gland, and are positively correlated with the tumor weight. However, the mechanism is not clear. We then proposed AA may enhance nuclear factor kappaB (NF-κB) activation studied in human breast cancer cell line MCF-7 and rat mammary tumors. We hypothesized that AA enhanced tumor necrosis factor-α (TNF-α)-induced NF-κB signaling for the growth of the breast cancer cells. We also studied the correlation between NF-κB signaling and tumor weight in rat mammary tumor.
MCF-7 cells were pretreated with 0, 10, 50 and 100 μM AA for 48 hours, and then were stimulated with TNF-α. Western blot analysis was performed on whole cell lysates, cytosol and nuclear fractions for the NF-κB signaling protein expression. AA supplementation resulted in increasing pAkt /Akt levels, IκBα degradation, nuclear p65 expression and reduced cyclin D1 expression in MCF-7.
In study of rat mammary tumors, the tumor weight were positively correlated with pAkt/Akt ratio (r=0.6993, p=0.0009), were inversely correlated with IκBα expression (r=0.5319, p= 0.0751), were positively correlated with nuclear p65 expression (r=0.6282, p=0.0287) and were inversely correlated with cyclin D1 expression (r=0.7652, p <0.0001) in the mammary tumor.
It was concluded that AA enhanced Akt signaling resulted in increasing IκBα degradation and nuclear p65 expression for the growth of breast cancer.
en
dc.description.provenanceMade available in DSpace on 2021-06-08T04:13:37Z (GMT). No. of bitstreams: 1
ntu-99-R97441005-1.pdf: 7214096 bytes, checksum: e0ea47609c537fd88e00b9a597bc2ae7 (MD5)
Previous issue date: 2010
en
dc.description.tableofcontents誌謝…………………………………………………………… I
中文摘要……………………………………………………… II
英文摘要……………………………………………………… IV
目錄…………………………………………………………….V
圖表目錄……………………………………………………… VIII
第壹章 文獻回顧
一、乳癌簡介……………………………………………… 1
二、多元不飽和脂肪酸(Polyunsaturated Fatty Acids;PUFA). 2
1、簡介…………………………………………………….. 2
2、花生四烯酸之特性與代謝途徑…………………….. 3
3、n-6脂肪酸和乳癌間關係………………………………. 3
三、NF-κB(Nuclear Factor-kappa B ) …………………….. 4
1、簡介………………………………………………….. 4
2、訊息傳遞途徑………………………………….. 5
3、 NF-κB與癌症間關係……………………………. 6
第貳章 研究目的
一、研究動機……………………………………………… 8
二、實驗假說………………………………………… 8
三、實驗設計……………………………………… 9
四、研究之重要性…………………………………… 11
第參章 材料與方法
一、細胞培養……………………………………………… 12
1、MCF-7細胞…………………………………….. 12
2、解凍與繼代培養方法……………………………….. 12
二、配製1M Arachidonic acid與BSA………………………... 13
三、蛋白質定性與定量分析…………………………………. 13
1、蛋白質萃取 ………………………………………………. 13
2、蛋白質定量 …………………………………………. 17
3、電泳檢定--西方墨點法 (Western Blot) ……………….. 17
4、轉印………………………………………………... 19
5、酵素免疫染色法………………………………………... 20
6、冷光照相與定量…………………………………... 22
四、酵素免疫染色法(Immunocytochemistry) …………………. 22
五、統計方法………………………………………. 23
第肆章 實驗結果
一、不同濃度之AA與Akt磷酸化表現 ………………… 24
二、AA與Akt磷酸化、IκBα分解隨時間的變化…………….. 27
三、p65蛋白於細胞核中的表現……………………………… 29
四、NF-κB與Akt路徑間的關係……………………………. 31
五、下游蛋白cyclin D1之表現……………………………….. 33
六、大鼠乳腺腫瘤大小與Akt活化之相關性……………. 34
七、大鼠乳腺腫瘤大小與NF-κB相關蛋白表現之相關性…….. 36
第伍章 討論
一、實驗條件之建立………………………………….. 39
1、選擇細胞株……………………………………………… 39
2、培養環境…………………………………………… 39
3、決定AA濃度及其製備方式………………………….. 40
4、添加TNF-α原因……………………………………. 41
二、選用p-Akt路徑原因………………………………. 41
三、實驗結果部份………………………….. 42
1、添加不同濃度AA對Akt磷酸化之影響…………………. 42
2、單一濃度AA在時間軸上對Akt磷酸化以及IκBα分解之影響… 43
3、不同濃度AA對p65蛋白進入細胞核之影響………………. 44
4、添加Akt抑制劑對於NF-κB相關蛋白影響…………………… 44
5、cyclin-D1之調節……………………………………… 44
6、大鼠乳腺腫瘤中各蛋白之表現……………………… 45
第陸章 總結…………………………………………………….. 47
附錄 藥品試劑……………………………………………………… 48
參考文獻………………………………………………………50
dc.language.isozh-TW
dc.title探討花生四烯酸在TNF-α誘發NF-κB傳訊下促進乳癌增生之調控機制zh_TW
dc.titleThe effect of arachidonic acid on TNF-α-induced NF-κB signaling studied in human breast cancer cell line and rat mammary tumorsen
dc.typeThesis
dc.date.schoolyear98-2
dc.description.degree碩士
dc.contributor.oralexamcommittee黃青真,李明學,蕭培文
dc.subject.keyword花生四烯酸,乳癌,NF-kappaB,TNF-alpha,zh_TW
dc.subject.keywordArachidonic acid,breast cancer,NF-kappaB,TNF-alpha,en
dc.relation.page53
dc.rights.note未授權
dc.date.accepted2010-08-16
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept生理學研究所zh_TW
顯示於系所單位:生理學科所

文件中的檔案:
檔案 大小格式 
ntu-99-1.pdf
  目前未授權公開取用
7.05 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved